Summary
Normal subjects, fasted 60 h, and patients with insulin-dependent diabetes mellitus (IDDM), withdrawn from insulin and fasted overnight, were given phenylacetate orally and intravenously infused with [3-14C]lactate and 13C-bicarbonate. Rates of hepatic gluconeogenesis relative to Krebs cycle rates were estimated from the 14C distribution in glutamate from urinary phenylacetylglutamine. Assuming the 13C enrichment of breath CO2 was that of the CO2 fixed by pyruvate, the enrichment to be expected in blood glucose, if all hepatic glucose production had been by gluconeogenesis, was then estimated. That estimate was compared with the actual enrichment in blood glucose, yielding the fraction of glucose production due to gluconeogenesis. Relative rates were similar in the 60-h fasted healthy subjects and the diabetic patients. Conversion of oxaloacetate to phosphoenolpyruvate was two to eight times Krebs cycle flux and decarboxylation of pyruvate to acetyl-CoA, oxidized in the cycle, was less than one-30th the fixation by pyruvate of CO2. Thus, in estimating the contribution of a gluconeogenic substrate to glucose production by measuring the incorporation of label from the labelled substrate into glucose, dilution of label at the level of oxaloacetate is relatively small. Pyruvate cycling was as much as one-half the rate of conversion of pyruvate to oxaloacetate. Glucose and glutamate carbons were derived from oxaloacetate formed by similar pathways if not from a common pool. In the 60-h fasted subjects, over 80 % of glucose production was via gluconeogenesis. In the diabetic subjects the percentages averaged about 45 %.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
Abbreviations
- IDDM:
-
Insulin-dependent diabetes mellitus
- PEP:
-
phosphoenolpyruvate
References
Landau BR (1993) Estimating gluconeogenic rates in NIDDM. Adv Exp Med Biol 334: 209–220
Gay LJ, Schneiter Ph, Schutz Y, Di Vetta V, Jéquier E, Tappy L (1994) A non-invasive assessment of hepatic glycogen kinetics and post-absorptive gluconeogenesis in man. Diabetologia 37: 517–523
Ensemo E, Chandramouli V, Schumann WC, Kumaran K, Wahren J, Landau, BR (1992) Use of 14CO2 in estimating rates of gluconeogenesis. Am J Physiol 263: E36-E41
Magnusson I, Schumann WC, Bartsch GE et al. (1991) Noninvasive tracing of Krebs cycle metabolism in liver. J Biol Chem 266: 6975–6984
Kosugi K, Scofield RF, Chandramouli V, Kumaran K, Schumann WC, Landau BR (1986) Pathways of acetone’s metabolism in the rat. J Biol Chem 261: 3952–3957
Petersen KF, Cline GW, Blair JB, Shulman GI (1994) Substrate cycling between pyruvate and oxaloacetate in awake normal and 3,3 ′-5-triodo-L-thyronine-treated rats. Am J Physiol 267: E273-E277
Landau BR, Schumann WC, Chandramouli V, Magnusson I, Kumaran K, Wahren J (1993) 14C-labeled propionate metabolism in vivo and estimates of hepatic gluconeogenesis relative to Krebs cycle flux. Am J Physiol 265: E636-E647
Di Donato L, Des Rosiers C, Montgomery JA, David F, Garneau M, Brunengraber H (1993) Rates of gluconeogenesis and citric acid cycle in perfused livers, assessed from the mass spectrometric assay of the 13C labelling pattern of glutamate. J Biol Chem 268: 4170–4180
Katz J, Wals P, Lee W-N P (1993) Isotopomer studies of gluconeogenesis and the Krebs cycle with 13C-labeled lactate. J Biol Chem 268: 25509–25521
Baranyai JM, Blum JJ (1989) Quantitative analysis of intermediary metabolism in rat hepatocytes incubated in the presence and absence of ethanol with a substrate mixture including ketoleucine. Biochem J 258: 121–140
Jungermann K, Katz N (1989) Functional specialization of different hepatocyte populations. Physiol Rev 69: 708–764
Schumann WC, Magnusson I, Chandramouli V, Kumaran K, Wahren J, Landau BR (1991) Metabolism of [2-14C] acetate and its use in assessing hepatic Krebs cycle activity and gluconeogenesis. J Biol Chem 266: 6985–6990
Beylot M, Soloviev MV, David F, Landau BR, Brunengraber H (1995) Tracing hepatic gluconeogenesis relative to citric acid cycle activity in vitro and in vivo. J Biol Chem 270: 1509–1514
Nair KS, Ebenstein DB, Wahren J (1993) 13CO2 enrichment in hepatic vein versus arterial, peripheral venous and breath samples during L-(1-13C)leucine infusion. Clin Res 41: 124A (Abstract)
Rothman DL, Magnusson I, Katz LD, Shulman RG, Shulman GI (1991) Quantitation of hepatic glycogenolysis and gluconeogenesis in fasting humans with 13C NMR. Science 254: 573–576
Wahren J, Efendic S, Luft R, Hagenfeldt L, Bjorkman O, Felig P (1977) Influence of somatostatin on splanchnic metabolism in postabsorptive and 60-h fasted humans. J Clin Invest 59: 299–307
Wahren J, Felig P, Cerasi E, Luft R (1972) Splanchnic and peripheral glucose and amino acid metabolism in diabetes mellitus. J Clin Invest 51: 1870–1878
Wahren J, Hagenfeldt L, Felig P (1975) Splanchnic and leg exchange of glucose, amino acids, and free fatty acids during exercise in diabetes mellitus. J Clin Invest 55: 1303–1314
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Landau, B.R., Chandramouli, V., Schumann, W.C. et al. Estimates of Krebs cycle activity and contributions of gluconeogenesis to hepatic glucose production in fasting healthy subjects and IDDM patients. Diabetologia 38, 831–838 (1995). https://doi.org/10.1007/s001250050360
Received:
Revised:
Issue Date:
DOI: https://doi.org/10.1007/s001250050360